Midland, MI (November 1, 2017) – Impact Analytical, Inc. is excited to announce a strategic alliance with E.M.M.A International. This partnership will aide our common clients in navigating the complicated world of regulatory and quality compliance.
“Time to market is everything for our customers, whether they are a startup medical device manufacturer or a Fortune 500 company. This partnership allows us to accelerate the regulatory approval process by streamlining the analytical data exchange process behind the compliance process. For most customers, this will ultimately translate into lower costs too,” ” said Neil Chapman, Impact Chief Executive Officer. “We’re very appreciative of the E.M.M.A International team for sharing our vision of growth, and the importance of continued outstanding customer service.”
“With this partnership we believe we can help our combined client base increase their profitability through faster, more streamlined processes,” said Carmine Jabri, Chief Executive Officer of E.M.M.A International. “We look forward to enjoying a long term relationship with Impact Analytical.
Launched in 2015, Impact is a fully accredited, independent testing lab providing highly customized service and support to over 300 international customers. Impact is focused on providing best in class service to customers with demanding needs in the Pharmaceutical, Medical Device, Polymer and Specialty Chemical industries. Impact is registered by the FDA and licensed by the DEA along with being accredited to ISO 9001:2015.
Headquartered in Farmington Hills, MI, with offices in Clearwater, FL and York PA the team of experts at E.M.M.A. International (www.emmainternational.com) provide support to clients globally focusing on quality systems, regulatory, and compliance services for the Biotechnology, Pharmaceuticals, Medical Device and all other FDA regulated industries.